Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2026 · second_quarter · Q2
-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues
Source: Senate LDA
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
CONNECT for Health Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
H–1Bs for Physicians and the Healthcare Workforce Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
CONNECT for Health Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Resident Physician Shortage Reduction Act of 2025
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
United States Capitol Police Wellness Promotion Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
United States Capitol Police Wellness Promotion Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
United States Capitol Police Wellness Promotion Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
United States Capitol Police Wellness Promotion Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Invest in American Railroads Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Invest in American Railroads Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Invest in American Railroads Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Invest in American Railroads Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
BETTER Kidney Care Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BETTER Kidney Care Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BETTER Kidney Care Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BETTER Kidney Care Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Moving and Fostering Innovation to Revolutionize Smarter Transportation Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Disaster Safe Power Grid Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Disaster Safe Power Grid Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Disaster Safe Power Grid Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Disaster Safe Power Grid Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
S. 652 / H.R. 2630 Safe Step Act
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
FASTER Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2026 · first_quarter · Q1
Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Telehealth Modernization Act CONNECT for Health Act of 2025 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act Safe Step Act - Improving Seniors Timely Access to Care Act H-1Bs for the Physicians and Healthcare Workforce Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States
-Safe Step Act -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2025 · fourth_quarter · Q4
-Safe Step Act -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act Safe Step Act - Improving Seniors Timely Access to Care Act - One Big Beautiful Bill Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID - Issues related to animal testing in medical research
Telehealth Modernization Act CONNECT for Health Act of 2025 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues
Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2025 · third_quarter · Q3
Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act of 2021 Bringing Regulatory Advances into Neuroscience (BRAIN) Act Safe Step Act - Improving Seniors Timely Access to Care Act - One Big Beautiful Bill Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID - Issues related to animal testing in medical research
Telehealth Modernization Act Empowering Medicare Seniors to Negotiate Drug Prices Act CONNECT for Health Act of 2025 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth
-Safe Step Act -Issues related to step therapy reform -Issues related to telehealth access
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2025 · second_quarter · Q2
Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act of 2021 Bringing Regulatory Advances into Neuroscience (BRAIN) Act Safe Step Act - Improving Seniors Timely Access to Care Act - One Big Beautiful Bill Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID
Telehealth Modernization Act Empowering Medicare Seniors to Negotiate Drug Prices Act CONNECT for Health Act of 2021 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth
-Safe Step Act -Issues related to step therapy reform -Issues related to telehealth access
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2025 · first_quarter · Q1
Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act of 2021 Bringing Regulatory Advances into Neuroscience (BRAIN) Act Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID
Telehealth Modernization Act Empowering Medicare Seniors to Negotiate Drug Prices Act CONNECT for Health Act of 2021 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2024 · fourth_quarter · Q4
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2024 · third_quarter · Q3
S. 652 / H.R. 2630 Safe Step Act
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2024 · second_quarter · Q2
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2024 · first_quarter · Q1
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2023 · fourth_quarter · Q4
S. 652 / H.R. 2630 Safe Step Act
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2023 · third_quarter · Q3
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2023 · second_quarter · Q2
S. 652 / H.R. 2630 Safe Step Act
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2023 · first_quarter · Q1
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID
S. 652 / H.R. 2630 Safe Step Act
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · fourth_quarter · Q4
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · third_quarter · Q3
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · second_quarter · Q2
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · first_quarter · Q1
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · fourth_quarter · Q4
S. 368/ H.R. 1332: Telehealth Modernization Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 S. 1988/H.R. 5425: Protecting Rural Telehealth Access Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act H.R. 3447: Permanency for Audio-Only Telehealth Act H.R. 4040: Advancing Telehealth Beyond Covid-19 Act S. 610: Protecting Medicare and American Farmers from Sequester Cuts Act S. 1731: Medicare Audiologist Access and Services Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · third_quarter · Q3
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 1692/H.R.3354: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · second_quarter · Q2
S. 368/ H.R. 1332: Telehealth Modernization Act S. 748: Medicare Sequester Relief Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act Support extension of 3.75% increase to Medicare Physician Fee Schedule payments Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments, postponing Medicare sequestration cuts beyond 2021, and retaining telemedicine. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · first_quarter · Q1
S. 368/ H.R. 1332: Telehealth Modernization Act S. 748: Medicare Sequester Relief Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071 Empowering Medicare Seniors to Negotiate Drug Prices Act H.R. 315: The Medicare Sequester COVID Moratorium Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 1868: To prevent across-the-board direct spending cuts, and for other purposes. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Opposition for changes to the Six Protected Classes in Medicare Part D.
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth
-Safe Step Act -Issues related to step therapy reform
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
S. 652 / H.R. 2630 Safe Step Act
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS Urging support for continued authority to prescribe medications through telehealth
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
S. 652 / H.R. 2630 Safe Step Act
H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
S. 652 / H.R. 2630 Safe Step Act
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Support for implementation of proposed G2211 complexity add-on code in the MPFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 652 / H.R. 2630 Safe Step Act
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368 / H.R. 1332: Telehealth Modernization Act S. 833 / H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512 / H.R. 2903: CONNECT for Health Act of 2021 H.R. 2474: Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 464/ H.R. 2163: Safe Step Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 464/ H.R. 2163: Safe Step Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S.1692/H.R.3354: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 H.R. 5657: Medical Marijuana Research Act Supporting vaccine requirements for health care workers. Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 368/ H.R. 1332: Telehealth Modernization Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 S. 1988/H.R. 5425: Protecting Rural Telehealth Access Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act H.R. 3447: Permanency for Audio-Only Telehealth Act H.R. 4040: Advancing Telehealth Beyond Covid-19 Act S. 1731: Medicare Audiologist Access and Services Act Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 Support for creating a Neuroscience Center of Excellence at FDA Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 289/ H.R. 869: Research Investment to Spark the Economy (RISE) Act S. 610/ H.R. 16 67: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 Support for creating a Neuroscience Center of Excellence at FDA Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, and ensuring access to affordable health coverage. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE